Source:http://linkedlifedata.com/resource/pubmed/id/11381643
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
18
|
pubmed:dateCreated |
2001-5-30
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0012-0472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
4
|
pubmed:volume |
126
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
A403
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11381643-Child,
pubmed-meshheading:11381643-Clinical Trials as Topic,
pubmed-meshheading:11381643-Europe,
pubmed-meshheading:11381643-European Union,
pubmed-meshheading:11381643-Humans,
pubmed-meshheading:11381643-Pediatrics,
pubmed-meshheading:11381643-Pharmaceutical Preparations,
pubmed-meshheading:11381643-Practice Guidelines as Topic
|
pubmed:year |
2001
|
pubmed:articleTitle |
[New guidelines of the European Union. Motivation for drug testing in pediatrics].
|
pubmed:publicationType |
News
|